Table 8.
Medications in patients with inflammatory bowel disease.a
| Overall | Crohn's disease | Ulcerative colitis | P value | |
|---|---|---|---|---|
| 5-ASA | 297 (71.6) | 141 (58.5) | 156 (89.7) | <.0001 |
| Azathioprine | 252 (60.7) | 164 (68.0) | 88 (50.6) | .0003 |
| Corticosteroid | 149 (35.9) | 70 (29.0) | 79 (45.4) | .0006 |
| Infliximab | 124 (29.9) | 90 (37.3) | 34 (19.5) | <.0001 |
| Adalimumab | 93 (22.4) | 76 (31.5) | 17 (9.8) | <.0001 |
| Vedolizumab | 28 (6.8) | 17 (7.1) | 11 (6.3) | .7692 |
| Omeprazole | 17 (4.1) | 13 (5.4) | 4 (2.3) | .1374 |
| Ustekinumab | 14 (3.4) | 12 (5) | 2 (1.2) | .0502 |
| Methotrexate | 1 (0.2) | 0 | 1 (0.6) | .4193 |
Data are n (%).
a
The medication history of 20 patients was not available.